0000899243-21-006362.txt : 20210212
0000899243-21-006362.hdr.sgml : 20210212
20210212175213
ACCESSION NUMBER: 0000899243-21-006362
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210210
FILED AS OF DATE: 20210212
DATE AS OF CHANGE: 20210212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pienta Kenneth
CENTRAL INDEX KEY: 0001571862
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38327
FILM NUMBER: 21630316
MAIL ADDRESS:
STREET 1: C/O CURIS, INC.
STREET 2: 4 MAGUIRE ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cue Biopharma, Inc.
CENTRAL INDEX KEY: 0001645460
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473324577
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21 ERIE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-949-2680
MAIL ADDRESS:
STREET 1: 21 ERIE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Imagen Biopharma, Inc.
DATE OF NAME CHANGE: 20150617
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-10
0
0001645460
Cue Biopharma, Inc.
CUE
0001571862
Pienta Kenneth
C/O CUE BIOPHARMA, INC.
21 ERIE STREET
CAMBRIDGE
MA
02139
0
1
0
0
Chief Medical Officer
Stock Option (right to buy)
15.55
2021-02-10
4
A
0
50000
0.00
A
2031-02-09
Common Stock
50000
50000
D
This stock option grant becomes exercisable in eight equal semi-annual installments beginning August 10, 2021.
/s/ Kenneth Pienta by Colin Sandercock, attorney-in-fact
2021-02-12